This shift suppressed intestinal FXR signaling and ameliorated high-fat diet (HFD)-induced metabolic dysfunction, including glucose intolerance, hepatic steatosis, and systemic inflammation. This evidence concerns the gene NR1H4 and Hepatic steatosis.